New combo attack on tough gynecologic cancers
NCT ID NCT04395079
Summary
This study is testing whether combining a targeted form of internal radiation (brachytherapy) with immunotherapy drugs can help control advanced gynecologic cancers that have stopped responding to standard platinum-based chemotherapy. It aims to see if this two-pronged approach is safe and can slow or stop cancer growth better than current options. The trial is for women with recurrent or spreading ovarian, endometrial, or cervical cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT MALIGNANT FEMALE REPRODUCTIVE SYSTEM NEOPLASM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UCLA / Jonsson Comprehensive Cancer Center
Los Angeles, California, 90095, United States
Conditions
Explore the condition pages connected to this study.